F&FFinancial Insights

Financial Metrics

PRGO PERRIGO Co plc
Range: 2016-01-01 to 2026-04-29
Chart Range:
% Change:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-04-02 1347300000.0 USD 10-Q 2017-05-30
Quarterly 2016-07-02 1340500000.0 -0.5% USD 10-Q 2017-08-10
Quarterly 2016-10-01 1261600000.0 -5.9% USD 10-Q 2017-11-09
Quarterly 2017-04-01 1194000000.0 -5.4% USD 10-Q 2018-05-08
Quarterly 2017-07-01 1237900000.0 +3.7% USD 10-Q 2018-08-09
Quarterly 2017-09-30 1231300000.0 -0.5% USD 10-Q 2018-11-08
Quarterly 2018-03-31 1217000000.0 -1.2% USD 10-Q 2019-05-09
Quarterly 2018-06-30 1186400000.0 -2.5% USD 10-Q 2019-08-08
Quarterly 2018-09-29 1133100000.0 -4.5% USD 10-Q 2019-11-06
Quarterly 2019-03-30 1174500000.0 +3.7% USD 10-Q 2020-05-05
Quarterly 2019-06-29 1149000000.0 -2.2% USD 10-Q 2020-08-05
Quarterly 2019-09-28 1191100000.0 +3.7% USD 10-Q 2020-11-05
Quarterly 2020-03-28 1083300000.0 -9.1% USD 10-Q 2021-05-12
Quarterly 2020-06-27 948800000.0 -12.4% USD 10-Q 2021-08-11
Quarterly 2020-09-26 1003000000.0 +5.7% USD 10-Q 2021-11-12
Quarterly 2021-04-03 1010000000.0 +0.7% USD 10-Q 2022-05-11
Quarterly 2021-07-03 981100000.0 -2.9% USD 10-Q 2022-08-09
Quarterly 2021-10-02 1042700000.0 +6.3% USD 10-Q 2022-11-08
Quarterly 2022-04-02 1074500000.0 +3.0% USD 10-Q 2023-05-09
Quarterly 2022-07-02 1121700000.0 +4.4% USD 10-Q 2023-08-08
Quarterly 2022-10-01 1100200000.0 -1.9% USD 10-Q 2023-11-07
Quarterly 2023-04-01 1181700000.0 +7.4% USD 10-Q 2024-05-07
Quarterly 2023-07-01 1193100000.0 +1.0% USD 10-Q 2024-08-02
Quarterly 2023-09-30 1123800000.0 -5.8% USD 10-Q 2024-11-06
Quarterly 2024-03-30 1082100000.0 -3.7% USD 10-Q 2025-05-07
Quarterly 2024-06-29 1065500000.0 -1.5% USD 10-Q 2025-08-06
Quarterly 2024-09-28 1087500000.0 +2.1% USD 10-Q 2025-11-05
Quarterly 2025-03-29 1043900000.0 -4.0% USD 10-Q 2025-05-07
Quarterly 2025-06-28 1056300000.0 +1.2% USD 10-Q 2025-08-06
Quarterly 2025-09-27 1043300000.0 -1.2% USD 10-Q 2025-11-05
Annual 2016-12-31 5280600000.0 USD 10-K 2019-02-27
Annual 2017-12-31 4946200000.0 -6.3% USD 10-K 2020-02-27
Annual 2018-12-31 4731700000.0 -4.3% USD 10-K 2021-03-01
Annual 2019-12-31 3869900000.0 -18.2% USD 10-K 2022-03-01
Annual 2020-12-31 4088200000.0 +5.6% USD 10-K 2023-02-28
Annual 2021-12-31 4138700000.0 +1.2% USD 10-K 2024-02-27
Annual 2022-12-31 4451600000.0 +7.6% USD 10-K 2025-02-28
Annual 2023-12-31 4655600000.0 +4.6% USD 10-K 2026-02-26
Annual 2024-12-31 4373400000.0 -6.1% USD 10-K 2026-02-26
Annual 2025-12-31 4253100000.0 -2.8% USD 10-K 2026-02-26

Gross Profit

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-04-02 533100000.0 USD 10-Q 2017-05-30
Quarterly 2016-07-02 546500000.0 +2.5% USD 10-Q 2017-08-10
Quarterly 2016-10-01 484500000.0 -11.3% USD 10-Q 2017-11-09
Quarterly 2017-04-01 464400000.0 -4.1% USD 10-Q 2018-05-08
Quarterly 2017-07-01 504600000.0 +8.7% USD 10-Q 2018-08-09
Quarterly 2017-09-30 497800000.0 -1.3% USD 10-Q 2018-11-08
Quarterly 2018-03-31 492700000.0 -1.0% USD 10-Q 2019-05-09
Quarterly 2018-06-30 471000000.0 -4.4% USD 10-Q 2019-08-08
Quarterly 2018-09-29 424800000.0 -9.8% USD 10-Q 2019-11-06
Quarterly 2019-03-30 448800000.0 +5.6% USD 10-Q 2020-05-05
Quarterly 2019-06-29 430800000.0 -4.0% USD 10-Q 2020-08-05
Quarterly 2019-09-28 412800000.0 -4.2% USD 10-Q 2020-11-05
Quarterly 2020-03-28 393700000.0 -4.6% USD 10-Q 2021-05-12
Quarterly 2020-06-27 347200000.0 -11.8% USD 10-Q 2021-08-11
Quarterly 2020-09-26 369700000.0 +6.5% USD 10-Q 2021-11-12
Quarterly 2021-04-03 368400000.0 -0.4% USD 10-Q 2022-05-11
Quarterly 2021-07-03 349000000.0 -5.3% USD 10-Q 2022-08-09
Quarterly 2021-10-02 336400000.0 -3.6% USD 10-Q 2022-11-08
Quarterly 2022-04-02 337800000.0 +0.4% USD 10-Q 2023-05-09
Quarterly 2022-07-02 372100000.0 +10.2% USD 10-Q 2023-08-08
Quarterly 2022-10-01 362900000.0 -2.5% USD 10-Q 2023-11-07
Quarterly 2023-04-01 413800000.0 +14.0% USD 10-Q 2024-05-07
Quarterly 2023-07-01 428000000.0 +3.4% USD 10-Q 2024-08-02
Quarterly 2023-09-30 411200000.0 -3.9% USD 10-Q 2024-11-06
Quarterly 2024-03-30 357700000.0 -13.0% USD 10-Q 2025-05-07
Quarterly 2024-06-29 394700000.0 +10.3% USD 10-Q 2025-08-06
Quarterly 2024-09-28 404400000.0 +2.5% USD 10-Q 2025-11-05
Quarterly 2025-03-29 392300000.0 -3.0% USD 10-Q 2025-05-07
Quarterly 2025-06-28 362900000.0 -7.5% USD 10-Q 2025-08-06
Quarterly 2025-09-27 377100000.0 +3.9% USD 10-Q 2025-11-05
Annual 2016-12-31 2051800000.0 USD 10-K 2019-02-27
Annual 2017-12-31 1979500000.0 -3.5% USD 10-K 2020-02-27
Annual 2018-12-31 1831500000.0 -7.5% USD 10-K 2021-03-01
Annual 2019-12-31 1433700000.0 -21.7% USD 10-K 2022-03-01
Annual 2020-12-31 1494900000.0 +4.3% USD 10-K 2023-02-28
Annual 2021-12-31 1416200000.0 -5.3% USD 10-K 2024-02-27
Annual 2022-12-31 1455400000.0 +2.8% USD 10-K 2025-02-28
Annual 2023-12-31 1680400000.0 +15.5% USD 10-K 2026-02-26
Annual 2024-12-31 1542700000.0 -8.2% USD 10-K 2026-02-26
Annual 2025-12-31 1494500000.0 -3.1% USD 10-K 2026-02-26

Operating Income

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-04-02 -231600000.0 USD 10-Q 2017-05-30
Quarterly 2016-07-02 184800000.0 +179.8% USD 10-Q 2017-08-10
Quarterly 2016-10-01 -1468300000.0 -894.5% USD 10-Q 2017-11-09
Quarterly 2017-04-01 128500000.0 +108.8% USD 10-Q 2018-05-08
Quarterly 2017-07-01 148800000.0 +15.8% USD 10-Q 2018-08-09
Quarterly 2017-09-30 162400000.0 +9.1% USD 10-Q 2018-11-08
Quarterly 2018-03-31 156300000.0 -3.8% USD 10-Q 2019-05-09
Quarterly 2018-06-30 94700000.0 -39.4% USD 10-Q 2019-08-08
Quarterly 2018-09-29 -122000000.0 -228.8% USD 10-Q 2019-11-06
Quarterly 2019-03-30 102300000.0 +183.9% USD 10-Q 2020-05-05
Quarterly 2019-06-29 55000000.0 -46.2% USD 10-Q 2020-08-05
Quarterly 2019-09-28 54400000.0 -1.1% USD 10-Q 2020-11-05
Quarterly 2020-03-28 86400000.0 +58.8% USD 10-Q 2021-05-12
Quarterly 2020-06-27 62700000.0 -27.4% USD 10-Q 2021-08-11
Quarterly 2020-09-26 78500000.0 +25.2% USD 10-Q 2021-11-12
Quarterly 2021-04-03 51400000.0 -34.5% USD 10-Q 2022-05-11
Quarterly 2021-07-03 -125900000.0 -344.9% USD 10-Q 2022-08-09
Quarterly 2021-10-02 438300000.0 +448.1% USD 10-Q 2022-11-08
Quarterly 2022-04-02 21700000.0 -95.0% USD 10-Q 2023-05-09
Quarterly 2022-07-02 -6900000.0 -131.8% USD 10-Q 2023-08-08
Quarterly 2022-10-01 33100000.0 +579.7% USD 10-Q 2023-11-07
Quarterly 2023-04-01 48500000.0 +46.5% USD 10-Q 2024-05-07
Quarterly 2023-07-01 56800000.0 +17.1% USD 10-Q 2024-08-02
Quarterly 2023-09-30 62100000.0 +9.3% USD 10-Q 2024-11-06
Quarterly 2024-03-30 -55200000.0 -188.9% USD 10-Q 2025-05-07
Quarterly 2024-06-29 -26500000.0 +52.0% USD 10-Q 2025-08-06
Quarterly 2024-09-28 80400000.0 +403.4% USD 10-Q 2025-11-05
Quarterly 2025-03-29 46900000.0 -41.7% USD 10-Q 2025-05-07
Quarterly 2025-06-28 45400000.0 -3.2% USD 10-Q 2025-08-06
Quarterly 2025-09-27 72600000.0 +59.9% USD 10-Q 2025-11-05
Annual 2016-12-31 -1999700000.0 USD 10-K 2019-02-27
Annual 2017-12-31 598200000.0 +129.9% USD 10-K 2020-02-27
Annual 2018-12-31 236500000.0 -60.5% USD 10-K 2021-03-01
Annual 2019-12-31 174700000.0 -26.1% USD 10-K 2022-03-01
Annual 2020-12-31 265200000.0 +51.8% USD 10-K 2023-02-28
Annual 2021-12-31 410400000.0 +54.8% USD 10-K 2024-02-27
Annual 2022-12-31 78900000.0 -80.8% USD 10-K 2025-02-28
Annual 2023-12-31 151900000.0 +92.5% USD 10-K 2026-02-26
Annual 2024-12-31 112900000.0 -25.7% USD 10-K 2026-02-26
Annual 2025-12-31 -1122200000.0 -1094.0% USD 10-K 2026-02-26

Net Income

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-04-02 -529200000.0 USD 10-Q 2017-05-30
Quarterly 2016-07-02 -534300000.0 -1.0% USD 10-Q 2017-08-10
Quarterly 2016-10-01 -1590200000.0 -197.6% USD 10-Q 2017-11-09
Quarterly 2017-04-01 71600000.0 +104.5% USD 10-Q 2018-05-08
Quarterly 2017-07-01 -69600000.0 -197.2% USD 10-Q 2018-08-09
Quarterly 2017-09-30 44500000.0 +163.9% USD 10-Q 2018-11-08
Quarterly 2018-03-31 80800000.0 +81.6% USD 10-Q 2019-11-06
Quarterly 2018-06-30 36200000.0 -55.2% USD 10-Q 2019-11-06
Quarterly 2018-09-29 -67500000.0 -286.5% USD 10-Q 2019-11-06
Quarterly 2019-03-30 63900000.0 +194.7% USD 10-Q 2020-11-05
Quarterly 2019-06-29 9000000.0 -85.9% USD 10-Q 2020-11-05
Quarterly 2019-09-28 92200000.0 +924.4% USD 10-Q 2020-11-05
Quarterly 2020-03-28 106400000.0 +15.4% USD 10-Q 2021-11-12
Quarterly 2020-06-27 60600000.0 -43.0% USD 10-Q 2021-11-12
Quarterly 2020-09-26 -154600000.0 -355.1% USD 10-Q 2021-11-12
Quarterly 2021-04-03 38100000.0 +124.6% USD 10-Q 2022-11-08
Quarterly 2021-07-03 -57700000.0 -251.4% USD 10-Q 2022-11-08
Quarterly 2021-10-02 -58900000.0 -2.1% USD 10-Q 2022-11-08
Quarterly 2022-04-02 -2400000.0 +95.9% USD 10-Q 2023-11-07
Quarterly 2022-07-02 -65100000.0 -2612.5% USD 10-Q 2023-11-07
Quarterly 2022-10-01 -49400000.0 +24.1% USD 10-Q 2023-11-07
Quarterly 2023-04-01 -3000000.0 +93.9% USD 10-Q 2024-11-06
Quarterly 2023-07-01 8400000.0 +380.0% USD 10-Q 2024-11-06
Quarterly 2023-09-30 14200000.0 +69.0% USD 10-Q 2024-11-06
Quarterly 2024-03-30 2000000.0 -85.9% USD 10-Q 2025-11-05
Quarterly 2024-06-29 -108400000.0 -5520.0% USD 10-Q 2025-11-05
Quarterly 2024-09-28 -21000000.0 +80.6% USD 10-Q 2025-11-05
Quarterly 2025-03-29 -6400000.0 +69.5% USD 10-Q 2025-11-05
Quarterly 2025-06-28 -8400000.0 -31.2% USD 10-Q 2025-11-05
Quarterly 2025-09-27 7500000.0 +189.3% USD 10-Q 2025-11-05
Annual 2016-12-31 -4012800000.0 USD 10-K 2019-02-27
Annual 2017-12-31 119600000.0 +103.0% USD 10-K 2020-02-27
Annual 2018-12-31 131000000.0 +9.5% USD 10-K 2021-03-01
Annual 2019-12-31 146100000.0 +11.5% USD 10-K 2022-03-01
Annual 2020-12-31 -162600000.0 -211.3% USD 10-K 2023-02-28
Annual 2021-12-31 -68900000.0 +57.6% USD 10-K 2024-02-27
Annual 2022-12-31 -140600000.0 -104.1% USD 10-K 2025-02-28
Annual 2023-12-31 -12700000.0 +91.0% USD 10-K 2026-02-26
Annual 2024-12-31 -171800000.0 -1252.8% USD 10-K 2026-02-26
Annual 2025-12-31 -1425400000.0 -729.7% USD 10-K 2026-02-26

EPS Basic

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-04-02 -3.7 USD/shares 10-Q 2017-05-30
Quarterly 2016-07-02 -3.73 -0.8% USD/shares 10-Q 2017-08-10
Quarterly 2016-10-01 -11.1 -197.6% USD/shares 10-Q 2017-11-09
Quarterly 2017-04-01 0.5 +104.5% USD/shares 10-Q 2018-05-08
Quarterly 2017-07-01 -0.49 -198.0% USD/shares 10-Q 2018-08-09
Quarterly 2017-09-30 0.31 +163.3% USD/shares 10-Q 2018-11-08
Quarterly 2018-03-31 0.57 +83.9% USD/shares 10-Q 2019-05-09
Quarterly 2018-06-30 0.26 -54.4% USD/shares 10-Q 2019-08-08
Quarterly 2018-09-29 -0.49 -288.5% USD/shares 10-Q 2019-11-06
Quarterly 2019-03-30 0.47 +195.9% USD/shares 10-Q 2020-05-05
Quarterly 2019-06-29 0.07 -85.1% USD/shares 10-Q 2020-08-05
Quarterly 2019-09-28 0.68 +871.4% USD/shares 10-Q 2020-11-05
Quarterly 2020-03-28 0.78 +14.7% USD/shares 10-Q 2021-05-12
Quarterly 2020-06-27 0.44 -43.6% USD/shares 10-Q 2021-08-11
Quarterly 2020-09-26 -1.13 -356.8% USD/shares 10-Q 2021-11-12
Quarterly 2021-04-03 0.29 +125.7% USD/shares 10-Q 2022-05-11
Quarterly 2021-07-03 -0.43 -248.3% USD/shares 10-Q 2022-08-09
Quarterly 2021-10-02 -0.44 -2.3% USD/shares 10-Q 2022-11-08
Quarterly 2022-04-02 -0.02 +95.5% USD/shares 10-Q 2023-05-09
Quarterly 2022-07-02 -0.48 -2300.0% USD/shares 10-Q 2023-08-08
Quarterly 2022-10-01 -0.37 +22.9% USD/shares 10-Q 2023-11-07
Quarterly 2023-04-01 -0.02 +94.6% USD/shares 10-Q 2024-05-07
Quarterly 2023-07-01 0.06 +400.0% USD/shares 10-Q 2024-08-02
Quarterly 2023-09-30 0.1 +66.7% USD/shares 10-Q 2024-11-06
Quarterly 2024-03-30 0.01 -90.0% USD/shares 10-Q 2025-05-07
Quarterly 2024-06-29 -0.79 -8000.0% USD/shares 10-Q 2025-08-06
Quarterly 2024-09-28 -0.15 +81.0% USD/shares 10-Q 2025-11-05
Quarterly 2025-03-29 -0.05 +66.7% USD/shares 10-Q 2025-05-07
Quarterly 2025-06-28 -0.06 -20.0% USD/shares 10-Q 2025-08-06
Quarterly 2025-09-27 0.05 +183.3% USD/shares 10-Q 2025-11-05
Annual 2016-12-31 -28.01 USD/shares 10-K 2019-02-27
Annual 2017-12-31 0.84 +103.0% USD/shares 10-K 2020-02-27
Annual 2018-12-31 0.95 +13.1% USD/shares 10-K 2021-03-01
Annual 2019-12-31 1.07 +12.6% USD/shares 10-K 2022-03-01
Annual 2020-12-31 -1.2 -212.1% USD/shares 10-K 2023-02-28
Annual 2021-12-31 -0.52 +56.7% USD/shares 10-K 2024-02-27
Annual 2022-12-31 -1.04 -100.0% USD/shares 10-K 2025-02-28
Annual 2023-12-31 -0.09 +91.3% USD/shares 10-K 2026-02-26
Annual 2024-12-31 -1.25 -1288.9% USD/shares 10-K 2026-02-26
Annual 2025-12-31 -10.29 -723.2% USD/shares 10-K 2026-02-26

EPS Diluted

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-04-02 -3.7 USD/shares 10-Q 2017-05-30
Quarterly 2016-07-02 -3.73 -0.8% USD/shares 10-Q 2017-08-10
Quarterly 2016-10-01 -11.1 -197.6% USD/shares 10-Q 2017-11-09
Quarterly 2017-04-01 0.5 +104.5% USD/shares 10-Q 2018-05-08
Quarterly 2017-07-01 -0.49 -198.0% USD/shares 10-Q 2018-08-09
Quarterly 2017-09-30 0.31 +163.3% USD/shares 10-Q 2018-11-08
Quarterly 2018-03-31 0.57 +83.9% USD/shares 10-Q 2019-05-09
Quarterly 2018-06-30 0.26 -54.4% USD/shares 10-Q 2019-08-08
Quarterly 2018-09-29 -0.49 -288.5% USD/shares 10-Q 2019-11-06
Quarterly 2019-03-30 0.47 +195.9% USD/shares 10-Q 2020-05-05
Quarterly 2019-06-29 0.07 -85.1% USD/shares 10-Q 2020-08-05
Quarterly 2019-09-28 0.67 +857.1% USD/shares 10-Q 2020-11-05
Quarterly 2020-03-28 0.77 +14.9% USD/shares 10-Q 2021-05-12
Quarterly 2020-06-27 0.44 -42.9% USD/shares 10-Q 2021-08-11
Quarterly 2020-09-26 -1.12 -354.5% USD/shares 10-Q 2021-11-12
Quarterly 2021-04-03 0.28 +125.0% USD/shares 10-Q 2022-05-11
Quarterly 2021-07-03 -0.43 -253.6% USD/shares 10-Q 2022-08-09
Quarterly 2021-10-02 -0.44 -2.3% USD/shares 10-Q 2022-11-08
Quarterly 2022-04-02 -0.02 +95.5% USD/shares 10-Q 2023-05-09
Quarterly 2022-07-02 -0.48 -2300.0% USD/shares 10-Q 2023-08-08
Quarterly 2022-10-01 -0.37 +22.9% USD/shares 10-Q 2023-11-07
Quarterly 2023-04-01 -0.02 +94.6% USD/shares 10-Q 2024-05-07
Quarterly 2023-07-01 0.06 +400.0% USD/shares 10-Q 2024-08-02
Quarterly 2023-09-30 0.1 +66.7% USD/shares 10-Q 2024-11-06
Quarterly 2024-03-30 0.01 -90.0% USD/shares 10-Q 2025-05-07
Quarterly 2024-06-29 -0.79 -8000.0% USD/shares 10-Q 2025-08-06
Quarterly 2024-09-28 -0.15 +81.0% USD/shares 10-Q 2025-11-05
Quarterly 2025-03-29 -0.05 +66.7% USD/shares 10-Q 2025-05-07
Quarterly 2025-06-28 -0.06 -20.0% USD/shares 10-Q 2025-08-06
Quarterly 2025-09-27 0.05 +183.3% USD/shares 10-Q 2025-11-05
Annual 2016-12-31 -28.01 USD/shares 10-K 2019-02-27
Annual 2017-12-31 0.84 +103.0% USD/shares 10-K 2020-02-27
Annual 2018-12-31 0.95 +13.1% USD/shares 10-K 2021-03-01
Annual 2019-12-31 1.07 +12.6% USD/shares 10-K 2022-03-01
Annual 2020-12-31 -1.19 -211.2% USD/shares 10-K 2023-02-28
Annual 2021-12-31 -0.52 +56.3% USD/shares 10-K 2024-02-27
Annual 2022-12-31 -1.04 -100.0% USD/shares 10-K 2025-02-28
Annual 2023-12-31 -0.09 +91.3% USD/shares 10-K 2026-02-26
Annual 2024-12-31 -1.25 -1288.9% USD/shares 10-K 2026-02-26
Annual 2025-12-31 -10.29 -723.2% USD/shares 10-K 2026-02-26

8-K Material Event Details

70 filings · 132 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

403 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value

All Transactions

Date Insider Title Type Security Shares Price Total Value Post-Tx Shares
2026-04-02 Willis Robert EVP & CHRO Exercise / conversion
M · derivative
Restricted Stock Units 2,070 2,070
2026-04-02 Willis Robert EVP & CHRO Other disposed transaction
F
Ordinary Shares 1,081 $10.85 $11,729 48,924
2026-04-02 Willis Robert EVP & CHRO Exercise / conversion
M
Ordinary Shares 2,070 $10.85 $22,460 50,005
2026-03-13 Parker Geoffrey M. Dir Equity grant / award
A · derivative
Restricted Stock Units 3,024 3,024
2026-03-06 Willis Robert EVP & CHRO Exercise / conversion
M · derivative
Restricted Stock Units 1,758 0
2026-03-06 Willis Robert EVP & CHRO Exercise / conversion
M · derivative
Restricted Stock Units 2,743 2,742
2026-03-06 Willis Robert EVP & CHRO Other disposed transaction
F
Ordinary Shares 4,178 $10.72 $44,788 47,935
2026-03-06 Willis Robert EVP & CHRO Equity grant / award
A
Ordinary Shares 8,019 $10.72 $85,964 52,113
2026-03-06 Willis Robert EVP & CHRO Other disposed transaction
F
Ordinary Shares 916 $10.72 $9,820 44,094
2026-03-06 Willis Robert EVP & CHRO Exercise / conversion
M
Ordinary Shares 1,758 $10.72 $18,846 45,010
2026-03-06 Willis Robert EVP & CHRO Other disposed transaction
F
Ordinary Shares 1,430 $10.72 $15,330 43,252
2026-03-06 Willis Robert EVP & CHRO Exercise / conversion
M
Ordinary Shares 2,743 $10.72 $29,405 44,682
2026-02-06 Lennox Abigail EVP and CSO Exercise / conversion
M · derivative
Restricted Stock Units 3,185 6,368
2026-02-06 Lennox Abigail EVP and CSO Other disposed transaction
F
Ordinary Shares 1,660 $14.64 $24,302 2,780
2026-02-06 Lennox Abigail EVP and CSO Exercise / conversion
M
Ordinary Shares 3,185 $14.64 $46,628 4,440
2025-12-12 Alford Bradley A Dir Equity grant / award
A · derivative
Restricted Stock Units 2,140 2,140
2025-11-12 Parker Geoffrey M. Dir Open-market buy
P
Ordinary Shares 7,500 $14.18 $106,350 17,375
2025-09-12 Parker Geoffrey M. Dir Equity grant / award
A · derivative
Restricted Stock Units 1,263 1,263
2025-09-09 Ball David EVP & CBDO Exercise / conversion
M · derivative
Restricted Stock Units 7,701 7,701
2025-09-09 Ball David EVP & CBDO Other disposed transaction
F
Ordinary Shares 2,784 $22.28 $62,028 4,917
2025-09-09 Ball David EVP & CBDO Exercise / conversion
M
Ordinary Shares 7,701 $22.28 $171,578 7,701
2025-09-08 Lennox Abigail EVP and CSO Open-market buy
P
Ordinary Shares 1,255 $22.41 $28,125 1,255
2025-09-05 Atkinson Charles EVP, General Counsel & Sec. Open-market buy
P
Ordinary Shares 1,000 $23.20 $23,200 1,000
2025-08-22 Willis Robert EVP & CHRO Open-market buy
P
Ordinary Shares 1,488 $24.10 $35,858 41,939
2025-08-18 Parker Geoffrey M. Dir Open-market buy
P
Ordinary Shares 4,375 $22.97 $100,497 33,287
2025-08-18 Parker Geoffrey M. Dir Open-market buy
P
Ordinary Shares 4,375 $22.97 $100,497 9,875
2025-08-08 Lockwood-Taylor Patrick CEO Open-market buy
P
Ordinary Shares 54 $22.37 $1,208 85,812
2025-08-08 Lockwood-Taylor Patrick CEO Open-market buy
P
Ordinary Shares 346 $22.38 $7,743 85,758
2025-08-08 Lockwood-Taylor Patrick CEO Open-market buy
P
Ordinary Shares 4,060 $22.37 $90,815 85,412
2025-07-10 Lockwood-Taylor Patrick CEO Exercise / conversion
M · derivative
Restricted Stock Units 28,326 28,325
2025-07-10 Lockwood-Taylor Patrick CEO Other disposed transaction
F
Ordinary Shares 14,234 $27.27 $388,161 81,352
2025-07-10 Lockwood-Taylor Patrick CEO Exercise / conversion
M
Ordinary Shares 28,326 $27.27 $772,450 95,586
2025-07-08 Winterman Matthew John EVP, Supply, Ops, Strategy Equity grant / award
A · derivative
Restricted Stock Units 5,527 5,527
2025-07-08 Winterman Matthew John EVP, Supply, Ops, Strategy Equity grant / award
A · derivative
Restricted Stock Units 31,319 31,319
2025-06-13 Alford Bradley A Dir Equity grant / award
A · derivative
Restricted Stock Units 976 976
2025-06-06 Ball David EVP & CBDO Equity grant / award
A · derivative
Restricted Stock Units 8,601 8,601
2025-05-14 Egan Kevin Francis Dir Equity grant / award
A · derivative
Restricted Stock Units 7,305 7,305
2025-05-12 Parker Geoffrey M. Dir Open-market buy
P
Ordinary Shares 3,500 $27.10 $94,850 23,762
2025-04-04 Janish Ronald Craig EVP, Gbl Ops & SC & CTO Exercise / conversion
M · derivative
Restricted Stock Units 2,707 5,414
2025-04-04 Janish Ronald Craig EVP, Gbl Ops & SC & CTO Other disposed transaction
F
Ordinary Shares 815 $26.31 $21,443 35,558
2025-04-04 Janish Ronald Craig EVP, Gbl Ops & SC & CTO Exercise / conversion
M
Ordinary Shares 2,707 $26.31 $71,221 36,373
2025-03-06 Samuelson Jonas Dir Equity grant / award
A · derivative
Restricted Stock Units 3,066 3,066
2025-03-05 Brown Julia M Dir Exercise / conversion
M · derivative
Restricted Stock Units 5,548 0
2025-03-05 Brown Julia M Dir Other disposed transaction
F
Ordinary Shares 2,664 $29.47 $78,508 2,884
2025-03-05 Brown Julia M Dir Exercise / conversion
M
Ordinary Shares 5,548 $29.47 $163,500 5,548
2025-02-07 Lennox Abigail EVP and CSO Equity grant / award
A · derivative
Restricted Stock Units 9,553 9,553
2024-12-09 KINDLER JEFFREY B Dir Open-market sell
S
Ordinary Shares 17,598 $28.27 $497,495 5,409
2024-10-04 Schmelter Triona EVP & President CSCA Exercise / conversion
M · derivative
Restricted Stock Units 1,970 3,939
2024-10-04 Schmelter Triona EVP & President CSCA Exercise / conversion
M · derivative
Restricted Stock Units 1,641 0
2024-10-04 Schmelter Triona EVP & President CSCA Other disposed transaction
F
Ordinary Shares 564 $24.93 $14,061 2,577
2024-10-04 Schmelter Triona EVP & President CSCA Exercise / conversion
M
Ordinary Shares 1,970 $24.93 $49,112 3,141
2024-10-04 Schmelter Triona EVP & President CSCA Other disposed transaction
F
Ordinary Shares 470 $24.93 $11,717 1,171
2024-10-04 Schmelter Triona EVP & President CSCA Exercise / conversion
M
Ordinary Shares 1,641 $24.93 $40,910 1,641
2024-09-13 Doyle Katherine C. Dir Open-market sell
S
Ordinary Shares 8,954 $27.30 $244,444 6,009
2024-09-09 Ball David EVP & CBDO Equity grant / award
A · derivative
Restricted Stock Units 15,402 15,402
2024-08-26 Janish Ronald Craig EVP, Gbl Ops & SC & CTO Open-market sell
S
Ordinary Shares 13,000 $29.40 $382,246 20,553
2024-08-20 Andersen Svend EVP & President CHCI Open-market sell
S
Ordinary Shares 6,683 $27.43 $183,281 7,000
2024-08-20 Andersen Svend EVP & President CHCI Open-market sell
S
Ordinary Shares 7,800 $27.45 $214,149 73,553
2024-08-20 Andersen Svend EVP & President CHCI Open-market sell
S
Ordinary Shares 20,500 $27.86 $571,130 81,353
2024-07-10 Lockwood-Taylor Patrick CEO Exercise / conversion
M · derivative
Restricted Stock Units 28,326 56,651
2024-07-10 Lockwood-Taylor Patrick CEO Other disposed transaction
F
Ordinary Shares 4,280 $27.16 $116,245 45,409
2024-07-10 Lockwood-Taylor Patrick CEO Equity grant / award
A
Ordinary Shares 11,837 $27.16 $321,493 49,689
2024-07-10 Lockwood-Taylor Patrick CEO Other disposed transaction
F
Ordinary Shares 10,974 $27.16 $298,054 37,852
2024-07-10 Lockwood-Taylor Patrick CEO Exercise / conversion
M
Ordinary Shares 28,326 $27.16 $769,334 48,826
2024-07-08 Ives Alison EVP & Chief Scientific Officer Exercise / conversion
M · derivative
Restricted Stock Units 920 919
2024-07-08 Ives Alison EVP & Chief Scientific Officer Other disposed transaction
F
Ordinary Shares 479 $25.72 $12,320 18,451
2024-07-08 Ives Alison EVP & Chief Scientific Officer Exercise / conversion
M
Ordinary Shares 920 $25.72 $23,662 18,930
2024-06-07 KINGMA TODD W Executive VP, General Counsel Equity grant / award
A · derivative
Restricted Stock Units 21,715 21,715
2024-05-28 Andersen Svend EVP & President CHCI Open-market buy
P
Ordinary Shares 1,000 $27.90 $27,900 101,853
2024-05-15 Parker Geoffrey M. Dir Exercise / conversion
M · derivative
Restricted Stock Units 8,764 0
2024-05-15 Parker Geoffrey M. Dir Other disposed transaction
F
Ordinary Shares 4,207 $30.22 $127,136 20,262
2024-05-15 Parker Geoffrey M. Dir Exercise / conversion
M
Ordinary Shares 8,764 $30.22 $264,848 24,469
2024-05-14 Parker Geoffrey M. Dir Equity grant / award
A · derivative
Restricted Stock Units 9,904 9,904
2024-04-05 Andersen Svend EVP & President CHCI Equity grant / award
A · derivative
Restricted Stock Units 13,376 13,376
2024-04-05 Bezerra Eduardo Guarita EVP & Chief Financial Officer Equity grant / award
A · derivative
Restricted Stock Units 19,108 19,108
2024-03-07 Quinn Grainne EVP, Chief Medical Officer Exercise / conversion
M · derivative
Restricted Stock Units 2,249 2,249
2024-03-07 Quinn Grainne EVP, Chief Medical Officer Other disposed transaction
F
Ordinary Shares 1,170 $29.69 $34,737 21,078
2024-03-07 Quinn Grainne EVP, Chief Medical Officer Exercise / conversion
M
Ordinary Shares 2,249 $29.69 $66,773 22,248
2024-03-06 Quinn Grainne EVP, Chief Medical Officer Exercise / conversion
M · derivative
Restricted Stock Units 1,759 3,517
2024-03-06 Quinn Grainne EVP, Chief Medical Officer Other disposed transaction
F
Ordinary Shares 915 $28.09 $25,702 19,999
2024-03-06 Quinn Grainne EVP, Chief Medical Officer Exercise / conversion
M
Ordinary Shares 1,759 $28.09 $49,410 20,914
2024-03-05 Ives Alison EVP & Chief Scientific Officer Exercise / conversion
M · derivative
Restricted Stock Units 1,698 0
2024-03-05 Ives Alison EVP & Chief Scientific Officer Other disposed transaction
F
Ordinary Shares 750 $27.26 $20,445 15,372
2024-03-05 Ives Alison EVP & Chief Scientific Officer Open-market buy
P
Ordinary Shares 2,490 $27.26 $67,877 16,122
2024-03-05 Ives Alison EVP & Chief Scientific Officer Other disposed transaction
F
Ordinary Shares 512 $27.26 $13,957 13,632
2024-03-05 Ives Alison EVP & Chief Scientific Officer Exercise / conversion
M
Ordinary Shares 1,698 $27.26 $46,287 14,144
2024-02-29 Ives Alison EVP & Chief Scientific Officer Open-market buy
P
Ordinary Shares 1,545 $26.44 $40,850 12,446
2023-11-24 Willis Robert EVP & CHRO Open-market buy
P
Ordinary Shares 5,550 $31.01 $172,106 19,105
2023-11-16 Ives Alison EVP & Chief Scientific Officer Open-market buy
P
Ordinary Shares 2,040 $29.34 $59,854 10,380
2023-11-16 Ives Alison EVP & Chief Scientific Officer Open-market buy
P
Ordinary Shares 2,040 $29.34 $59,854 10,901
2023-11-14 Bezerra Eduardo Guarita EVP & Chief Financial Officer Open-market buy
P
Ordinary Shares 5,000 $29.18 $145,882 8,428
2023-10-06 Schmelter Triona EVP & President CSCA Equity grant / award
A · derivative
Restricted Stock Units 5,909 5,909
2023-10-06 Schmelter Triona EVP & President CSCA Equity grant / award
A · derivative
Restricted Stock Units 1,641 1,641
2023-08-15 Manzone Albert Dir Exercise / conversion
M · derivative
Restricted Stock Units 5,478 0
2023-08-15 Manzone Albert Dir Other disposed transaction
F
Ordinary Shares 2,630 $38.88 $102,254 2,848
2023-08-15 Manzone Albert Dir Exercise / conversion
M
Ordinary Shares 5,478 $38.88 $212,985 5,478
2023-07-10 Lockwood-Taylor Patrick CEO Equity grant / award
A · derivative
Restricted Stock Units 84,977 84,977
2023-07-07 Ives Alison EVP & Chief Scientific Officer Exercise / conversion
M · derivative
Restricted Stock Units 920 1,839
2023-07-07 Ives Alison EVP & Chief Scientific Officer Other disposed transaction
F
Ordinary Shares 271 $32.63 $8,843 8,340
2023-07-07 Ives Alison EVP & Chief Scientific Officer Exercise / conversion
M
Ordinary Shares 920 $32.63 $30,020 8,611
2023-06-13 Parker Geoffrey M. Dir Open-market buy
P
Ordinary Shares 10,000 $33.06 $330,637 25,879
2023-06-07 Bezerra Eduardo Guarita EVP & Chief Financial Officer Exercise / conversion
M · derivative
Restricted Stock Units 4,532 9,063
2023-06-07 Bezerra Eduardo Guarita EVP & Chief Financial Officer Other disposed transaction
F
Ordinary Shares 1,104 $33.72 $37,227 3,428
2023-06-07 Bezerra Eduardo Guarita EVP & Chief Financial Officer Exercise / conversion
M
Ordinary Shares 4,532 $33.72 $152,819 4,532
2023-05-23 Andersen Svend EVP & President CHCI Open-market buy
P
Ordinary Shares 2,900 $33.41 $96,902 68,741
2023-05-17 ASHFORD ORLANDO D Dir Exercise / conversion
M · derivative
Restricted Stock Units 9,723 0
2023-05-17 ASHFORD ORLANDO D Dir Other disposed transaction
F
Ordinary Shares 4,668 $32.86 $153,390 10,037
2023-05-17 ASHFORD ORLANDO D Dir Exercise / conversion
M
Ordinary Shares 9,723 $32.86 $319,498 14,705
2023-05-15 O'Connor Donal Dir Equity grant / award
A · derivative
Restricted Stock Units 8,764 8,764
2023-05-11 KESSLER MURRAY S CEO Open-market sell
S
Ordinary Shares 197,646 $35.75 $7,066,358 2,668
2023-03-13 Farrington Thomas EVP and CIO Open-market sell
S
Ordinary Shares 200 $35.59 $7,118 2,823
2023-03-13 Farrington Thomas EVP and CIO Open-market sell
S
Ordinary Shares 3,523 $35.57 $125,317 3,023
2023-03-10 Dillard James E III EVP & President CSCA Open-market sell
S
Ordinary Shares 9,000 $35.70 $321,309 25,130
2023-03-08 Janish Ronald Craig EVP, Gbl Ops & SC & CTO Open-market sell
S
Ordinary Shares 4,500 $36.92 $166,133 20,191
2023-03-07 Farrington Thomas EVP and CIO Exercise / conversion
M · derivative
Restricted Stock Units 2,406 4,810
2023-03-07 Farrington Thomas EVP and CIO Other disposed transaction
F
Ordinary Shares 1,159 $37.71 $43,706 6,546
2023-03-07 Farrington Thomas EVP and CIO Exercise / conversion
M
Ordinary Shares 2,406 $37.71 $90,730 7,705
2023-03-07 Ives Alison EVP & Chief Scientific Officer Exercise / conversion
M · derivative
Restricted Stock Units 1,746 3,492
2023-03-07 Ives Alison EVP & Chief Scientific Officer Other disposed transaction
F
Ordinary Shares 510 $37.71 $19,232 7,691
2023-03-07 Ives Alison EVP & Chief Scientific Officer Exercise / conversion
M
Ordinary Shares 1,746 $37.71 $65,842 8,201
2023-03-06 Farrington Thomas EVP and CIO Equity grant / award
A · derivative
Restricted Stock Units 5,641 5,641
2023-03-03 Dillard James E III EVP & President CSCA Exercise / conversion
M · derivative
Restricted Stock Units 2,680 2,680
2023-03-03 Dillard James E III EVP & President CSCA Exercise / conversion
M · derivative
Restricted Stock Units 1,995 0
2023-03-03 Dillard James E III EVP & President CSCA Other disposed transaction
F
Ordinary Shares 1,209 $38.75 $46,849 31,091
2023-03-03 Dillard James E III EVP & President CSCA Exercise / conversion
M
Ordinary Shares 2,680 $38.75 $103,850 32,300
2023-03-03 Dillard James E III EVP & President CSCA Other disposed transaction
F
Ordinary Shares 900 $38.75 $34,875 29,620
2023-03-03 Dillard James E III EVP & President CSCA Exercise / conversion
M
Ordinary Shares 1,995 $38.75 $77,306 30,520
2023-03-03 Dillard James E III EVP & President CSCA Other disposed transaction
F
Ordinary Shares 4,690 $38.75 $181,738 28,525
2023-03-03 Dillard James E III EVP & President CSCA Equity grant / award
A
Ordinary Shares 10,277 $38.75 $398,234 33,215
2022-12-16 Quinn Grainne EVP, Chief Medical Officer Open-market sell
S
Ordinary Shares 2,368 $31.65 $74,947 9,118
2022-10-07 Ives Alison EVP & Chief Scientific Officer Exercise / conversion
M · derivative
Restricted Stock Units 739 738
2022-10-07 Ives Alison EVP & Chief Scientific Officer Other disposed transaction
F
Ordinary Shares 217 $38.09 $8,266 4,756
2022-10-07 Ives Alison EVP & Chief Scientific Officer Exercise / conversion
M
Ordinary Shares 739 $38.09 $28,149 4,973
2022-08-15 Manzone Albert Dir Equity grant / award
A · derivative
Restricted Stock Units 5,478 5,478
2022-07-08 Ives Alison EVP & Chief Scientific Officer Equity grant / award
A · derivative
Restricted Stock Units 2,759 2,759
2022-06-07 Bezerra Eduardo Guarita EVP & Chief Financial Officer Equity grant / award
A · derivative
Restricted Stock Units 13,595 13,595
2022-05-17 Karaboutis Adriana Dir Exercise / conversion
M · derivative
Restricted Stock Units 6,599 0
2022-05-17 Karaboutis Adriana Dir Equity grant / award
A · derivative
Restricted Stock Units 7,778 7,778
2022-05-17 Karaboutis Adriana Dir Other disposed transaction
F
Ordinary Shares 3,168 $38.57 $122,190 13,878
2022-05-17 Karaboutis Adriana Dir Exercise / conversion
M
Ordinary Shares 6,599 $38.57 $254,523 17,046
2022-04-05 SILCOCK RAYMOND EVP, Chief Financial Officer Exercise / conversion
M · derivative
Restricted Stock Units 3,963 0
2022-04-05 SILCOCK RAYMOND EVP, Chief Financial Officer Other disposed transaction
F
Ordinary Shares 1,467 $36.27 $53,208 59,488
2022-04-05 SILCOCK RAYMOND EVP, Chief Financial Officer Exercise / conversion
M
Ordinary Shares 3,963 $36.27 $143,738 60,955
2022-03-14 Farrington Thomas EVP and CIO Open-market sell
S
Ordinary Shares 2,259 $37.23 $84,103 0
2022-03-14 Farrington Thomas EVP and CIO Open-market sell
S
Ordinary Shares 24,485 $37.13 $909,079 0
2022-03-07 Willis Robert EVP & CHRO Equity grant / award
A · derivative
Restricted Stock Units 6,489 6,489
2022-03-04 Willis Robert EVP & CHRO Exercise / conversion
M · derivative
Restricted Stock Units 1,280 2,558
2022-03-04 Willis Robert EVP & CHRO Exercise / conversion
M · derivative
Restricted Stock Units 952 952
2022-03-04 Willis Robert EVP & CHRO Exercise / conversion
M · derivative
Restricted Stock Units 580 0
2022-03-04 Willis Robert EVP & CHRO Exercise / conversion
M · derivative
Restricted Stock Units 1,650 0
2022-03-04 Willis Robert EVP & CHRO Exercise / conversion
M · derivative
Restricted Stock Units 550 0
2022-03-04 Willis Robert EVP & CHRO Other disposed transaction
F
Ordinary Shares 666 $37.23 $24,795 9,094
2022-03-04 Willis Robert EVP & CHRO Exercise / conversion
M
Ordinary Shares 1,280 $37.23 $47,654 9,760
2022-03-04 Willis Robert EVP & CHRO Other disposed transaction
F
Ordinary Shares 496 $37.23 $18,466 8,480
2022-03-04 Willis Robert EVP & CHRO Exercise / conversion
M
Ordinary Shares 952 $37.23 $35,443 8,976
2022-03-04 Willis Robert EVP & CHRO Other disposed transaction
F
Ordinary Shares 302 $37.23 $11,243 8,024
2022-03-04 Willis Robert EVP & CHRO Exercise / conversion
M
Ordinary Shares 580 $37.23 $21,593 8,326
2022-03-04 Willis Robert EVP & CHRO Other disposed transaction
F
Ordinary Shares 858 $37.23 $31,943 7,746
2022-03-04 Willis Robert EVP & CHRO Exercise / conversion
M
Ordinary Shares 1,650 $37.23 $61,430 8,604
2022-03-04 Willis Robert EVP & CHRO Other disposed transaction
F
Ordinary Shares 286 $37.23 $10,648 6,954
2022-03-04 Willis Robert EVP & CHRO Exercise / conversion
M
Ordinary Shares 550 $37.23 $20,476 7,240
2022-03-04 Willis Robert EVP & CHRO Other disposed transaction
F
Ordinary Shares 1,122 $37.23 $41,772 6,690
2022-03-04 Willis Robert EVP & CHRO Equity grant / award
A
Ordinary Shares 2,156 $37.23 $80,268 7,812
2022-03-04 Willis Robert EVP & CHRO Other disposed transaction
F
Ordinary Shares 1,479 $37.23 $55,063 5,656
2022-03-04 Willis Robert EVP & CHRO Equity grant / award
A
Ordinary Shares 2,843 $37.23 $105,845 7,135
2022-02-07 Dillard James E III EVP & President CSCA Exercise / conversion
M · derivative
Restricted Stock Units 4,297 0
2022-02-07 Dillard James E III EVP & President CSCA Other disposed transaction
F
Ordinary Shares 2,059 $36.95 $76,080 12,841
2022-02-07 Dillard James E III EVP & President CSCA Exercise / conversion
M
Ordinary Shares 4,297 $36.95 $158,774 14,900
2021-12-17 KINGMA TODD W Executive VP, General Counsel Open-market buy
P
Ordinary Shares 3,000 $37.55 $112,648 51,856
2021-12-16 Parker Geoffrey M. Dir Open-market buy
P
Ordinary Shares 5,000 $36.85 $184,270 10,879
2021-12-06 Andersen Svend EVP & President CHCI Open-market buy
P
Ordinary Shares 1,255 $37.08 $46,535 13,683
2021-12-06 Andersen Svend EVP & President CHCI Open-market buy
P
Ordinary Shares 2,400 $37.11 $89,064 12,428
2021-12-03 SILCOCK RAYMOND EVP, Chief Financial Officer Open-market buy
P
Ordinary Shares 27,500 $36.03 $990,930 37,696
2021-12-02 CLASSON ROLF A Dir Open-market buy
P
Ordinary Shares 2,800 $35.67 $99,874 17,442
2021-08-12 Doyle Katherine C. Dir Exercise / conversion
M · derivative
Restricted Stock Units 5,637 0
2021-08-12 Doyle Katherine C. Dir Other disposed transaction
F
Ordinary Shares 2,706 $41.28 $111,704 2,931
2021-08-12 Doyle Katherine C. Dir Exercise / conversion
M
Ordinary Shares 5,637 $41.28 $232,695 5,637
2021-05-17 Mann Erica L Dir Equity grant / award
A · derivative
Restricted Stock Units 6,599 6,599
2021-05-07 Alford Bradley A Dir Exercise / conversion
M · derivative
Restricted Stock Units 5,804 0
2021-05-07 Alford Bradley A Dir Other disposed transaction
F
Ordinary Shares 2,786 $42.96 $119,687 10,978
2021-05-07 Alford Bradley A Dir Exercise / conversion
M
Ordinary Shares 5,804 $42.96 $249,340 13,764
2021-04-05 SILCOCK RAYMOND EVP, Chief Financial Officer Exercise / conversion
M · derivative
Restricted Stock Units 3,964 3,963
2021-04-05 SILCOCK RAYMOND EVP, Chief Financial Officer Exercise / conversion
M
Ordinary Shares 3,964 $40.39 $160,106 10,196
2021-03-17 Parker Geoffrey M. Dir Open-market buy
P
Ordinary Shares 2,500 $41.29 $103,218 2,650
2021-03-10 Janish Ronald Craig EVP, Gbl Ops & SC & CTO Open-market sell
S
Ordinary Shares 2,662 $41.23 $109,766 11,731
2021-03-05 ASHFORD ORLANDO D Dir Equity grant / award
A · derivative
Restricted Stock Units 2,984 2,984
2021-03-05 KESSLER MURRAY S CEO Equity grant / award
A · derivative
Restricted Stock Units 56,652 56,652
2021-03-05 KESSLER MURRAY S CEO Other disposed transaction
F
Ordinary Shares 5,683 $41.04 $233,230 43,482
2021-03-05 KESSLER MURRAY S CEO Exercise / conversion
M
Ordinary Shares 14,061 $41.04 $577,063 49,165
2021-03-05 KESSLER MURRAY S CEO Other disposed transaction
F
Ordinary Shares 6,622 $41.04 $271,767 35,104
2021-03-05 KESSLER MURRAY S CEO Exercise / conversion
M
Ordinary Shares 16,385 $41.04 $672,440 41,726
2021-02-05 Dillard James E III EVP, Chief Scientific Officer Exercise / conversion
M · derivative
Restricted Stock Units 4,297 4,297
2021-02-05 Dillard James E III EVP, Chief Scientific Officer Other disposed transaction
F
Ordinary Shares 1,396 $43.09 $60,154 7,517
2021-02-05 Dillard James E III EVP, Chief Scientific Officer Exercise / conversion
M
Ordinary Shares 4,297 $0.00 $0 8,913
2021-01-06 Sorota Richard S EVP & President CSCA Open-market buy
P
Ordinary Shares 7,513 $43.48 $326,665 7,513
2020-11-09 CLASSON ROLF A Dir Open-market buy
P
Ordinary Shares 2,137 $46.75 $99,898 10,870
2020-08-14 Willis Robert EVP & CHRO Exercise / conversion
M · derivative
Restricted Stock Units 581 1,160
2020-08-14 Willis Robert EVP & CHRO Other disposed transaction
F
Ordinary Shares 303 $53.40 $16,180 2,055
2020-08-14 Willis Robert EVP & CHRO Exercise / conversion
M
Ordinary Shares 581 $53.40 $31,025 2,358
2020-08-12 Doyle Katherine C. Dir Equity grant / award
A · derivative
Restricted Stock Units 5,637 5,637
2020-08-11 Andersen Svend EVP & President CHCI Open-market buy
P
Ordinary Shares 2,828 $53.01 $149,910 10,028
2020-06-29 Janish Ronald Craig EVP, Global Op. & Supply Chain Exercise / conversion
M · derivative
Restricted Stock Units 827 0
2020-06-29 Janish Ronald Craig EVP, Global Op. & Supply Chain Other disposed transaction
F
Ordinary Shares 361 $54.56 $19,696 9,068
2020-06-29 Janish Ronald Craig EVP, Global Op. & Supply Chain Exercise / conversion
M
Ordinary Shares 827 $54.56 $45,121 9,429
2020-06-05 Willis Robert EVP & CHRO Exercise / conversion
M · derivative
Restricted Stock Units 606 0
2020-06-05 Willis Robert EVP & CHRO Other disposed transaction
F
Ordinary Shares 316 $55.61 $17,573 1,648
2020-06-05 Willis Robert EVP & CHRO Exercise / conversion
M
Ordinary Shares 606 $55.61 $33,700 1,964
2020-05-15 Samuels Theodore R. II Dir Exercise / conversion
M · derivative
Restricted Stock Units 6,054 0
2020-05-15 Samuels Theodore R. II Dir Exercise / conversion
M
Ordinary Shares 6,054 $52.76 $319,409 14,290
2020-05-07 CLASSON ROLF A Dir Equity grant / award
A · derivative
Restricted Stock Units 7,255 7,255
2020-04-03 SILCOCK RAYMOND EVP, Chief Financial Officer Exercise / conversion
M · derivative
Restricted Stock Units 3,964 7,927
2020-04-03 SILCOCK RAYMOND EVP, Chief Financial Officer Other disposed transaction
F
Ordinary Shares 1,361 $44.36 $60,374 2,603
2020-04-03 SILCOCK RAYMOND EVP, Chief Financial Officer Exercise / conversion
M
Ordinary Shares 3,964 $44.36 $175,843 3,964
2020-03-13 Samuels Theodore R. II Dir Open-market buy
P
Ordinary Shares 2,000 $42.50 $85,000 13,618
2020-03-06 Andersen Svend EVP & President CHCI Exercise / conversion
M · derivative
Restricted Stock Units 2,960 5,919
2020-03-06 Andersen Svend EVP & President CHCI Other disposed transaction
F
Ordinary Shares 3,565 $53.17 $189,551 8,202
2020-03-06 Andersen Svend EVP & President CHCI Equity grant / award
A
Ordinary Shares 5,982 $53.17 $318,063 11,767
2020-03-06 Andersen Svend EVP & President CHCI Other disposed transaction
F
Ordinary Shares 885 $53.17 $47,055 5,785
2020-03-06 Andersen Svend EVP & President CHCI Equity grant / award
A
Ordinary Shares 1,485 $53.17 $78,957 6,670
2020-03-06 Andersen Svend EVP & President CHCI Other disposed transaction
F
Ordinary Shares 1,764 $53.17 $93,792 5,185
2020-03-06 Andersen Svend EVP & President CHCI Exercise / conversion
M
Ordinary Shares 2,960 $53.17 $157,383 6,949
2020-03-06 KESSLER MURRAY S CEO Exercise / conversion
M · derivative
Restricted Stock Units 16,385 32,769
2020-03-06 KESSLER MURRAY S CEO Other disposed transaction
F
Ordinary Shares 6,727 $53.17 $357,675 25,341
2020-03-06 KESSLER MURRAY S CEO Exercise / conversion
M
Ordinary Shares 16,385 $53.17 $871,190 32,068
2020-03-05 Janish Ronald Craig EVP, Global Op. & Supply Chain Equity grant / award
A · derivative
Restricted Stock Units 4,626
2020-02-07 Dillard James E III EVP, Chief Scientific Officer Exercise / conversion
M · derivative
Restricted Stock Units 4,298 8,594
2020-02-07 Dillard James E III EVP, Chief Scientific Officer Other disposed transaction
F
Ordinary Shares 1,342 $59.91 $80,399 2,956
2020-02-07 Dillard James E III EVP, Chief Scientific Officer Exercise / conversion
M
Ordinary Shares 4,298 $59.91 $257,493 4,298
2019-12-31 Needham Jeffrey EVP, President CHC Americas Exercise / conversion
M · derivative
Restricted Stock Units 6,169 0
2019-12-31 Needham Jeffrey EVP, President CHC Americas Other disposed transaction
F
Ordinary Shares 1,895 $51.66 $97,896 23,758
2019-12-31 Needham Jeffrey EVP, President CHC Americas Exercise / conversion
M
Ordinary Shares 6,169 $51.66 $318,691 25,653
2019-12-20 KINGMA TODD W Executive VP, General Counsel Open-market sell
S
Ordinary Shares 1,200 $54.91 $65,892 29,984
2019-12-20 KINGMA TODD W Executive VP, General Counsel Open-market sell
S
Ordinary Shares 1,100 $54.91 $60,401 31,184
2019-11-11 Quinn Grainne EVP, Chief Medical Officer Open-market sell
S
Ordinary Shares 2,050 $49.08 $100,614 3,047
2019-11-08 Janish Ronald Craig EVP, Global Op. & Supply Chain Open-market sell
S
Ordinary Shares 2,424 $49.90 $120,967 6,006
2019-10-08 Needham Jeffrey EVP, President CHC Americas Exercise / conversion
M · derivative
Restricted Stock Units 8,242 0
2019-10-08 Needham Jeffrey EVP, President CHC Americas Other disposed transaction
F
Ordinary Shares 2,164 $51.94 $112,398 19,484
2019-10-08 Needham Jeffrey EVP, President CHC Americas Exercise / conversion
M
Ordinary Shares 8,242 $51.94 $428,089 21,648
2019-08-22 Winowiecki Ronald CFO Open-market sell
S
Ordinary Shares 826 $48.03 $39,674 6,952
2019-08-15 Willis Robert EVP & CHRO Equity grant / award
A · derivative
Restricted Stock Units 1,741 $0.00 $0 1,741
2019-08-09 Samuels Theodore R. II Dir Open-market buy
P
Ordinary Shares 4,000 $46.97 $187,893 11,618
2019-07-19 Winowiecki Ronald CFO Exercise / conversion
M · derivative
Restricted Stock Units 2,296 0
2019-07-19 Winowiecki Ronald CFO Other disposed transaction
F
Ordinary Shares 1,002 $51.56 $51,663 7,778
2019-07-19 Winowiecki Ronald CFO Exercise / conversion
M
Ordinary Shares 2,296 $51.56 $118,382 8,780
2019-05-15 Karaboutis Adriana Dir Exercise / conversion
M · derivative
Restricted Stock Units 3,971 0
2019-05-15 Karaboutis Adriana Dir Equity grant / award
A · derivative
Restricted Stock Units 6,054 6,054
2019-05-15 Karaboutis Adriana Dir Other disposed transaction
F
Ordinary Shares 1,907 $49.55 $94,492 4,281
2019-05-15 Karaboutis Adriana Dir Exercise / conversion
M
Ordinary Shares 3,971 $0.00 $0 6,188
2019-04-05 SILCOCK RAYMOND EVP, Chief Financial Officer Equity grant / award
A · derivative
Restricted Stock Units 11,891 $0.00 $0 11,891
2019-03-06 Farrington Thomas EVP and CIO Equity grant / award
A · derivative
Restricted Stock Units 4,408 $0.00 $0 4,408
2019-02-26 Quinn Grainne EVP, Chief Medical Officer Exercise / conversion
M · derivative
Restricted Stock Units 254 0
2019-02-26 Quinn Grainne EVP, Chief Medical Officer Other disposed transaction
F
Ordinary Shares 133 $48.29 $6,423 2,693
2019-02-26 Quinn Grainne EVP, Chief Medical Officer Exercise / conversion
M
Ordinary Shares 254 $48.29 $12,266 2,826
2019-02-26 Quinn Grainne EVP, Chief Medical Officer Other disposed transaction
F
Ordinary Shares 192 $48.29 $9,272 2,572
2019-02-26 Quinn Grainne EVP, Chief Medical Officer Equity grant / award
A
Ordinary Shares 368 $48.29 $17,771 2,764
2019-02-26 Kochan Sharon EVP, GM International Exercise / conversion
M · derivative
Restricted Stock Units 1,315 0
2019-02-26 Kochan Sharon EVP, GM International Other disposed transaction
F
Ordinary Shares 734 $48.29 $35,445 12,189
2019-02-26 Kochan Sharon EVP, GM International Exercise / conversion
M
Ordinary Shares 1,315 $48.29 $63,501 12,923
2019-02-26 Kochan Sharon EVP, GM International Other disposed transaction
F
Ordinary Shares 1,064 $48.29 $51,381 11,608
2019-02-26 Kochan Sharon EVP, GM International Equity grant / award
A
Ordinary Shares 1,908 $48.29 $92,137 12,672
2019-02-07 Dillard James E III EVP, Chief Scientific Officer Equity grant / award
A · derivative
Restricted Stock Units 12,892 $0.00 $0 12,892
2018-11-14 COHEN GARY M Dir Exercise / conversion
M · derivative
Director Stock Option Right to Buy 3,053 $0.00 $0 0
2018-11-14 COHEN GARY M Dir Exercise / conversion
M
Ordinary Shares 3,053 $39.62 $120,960 20,317
2018-11-13 Samuels Theodore R. II Dir Open-market buy
P
Ordinary Shares 3,500 $65.40 $228,902 7,618
2018-11-12 Parker Geoffrey M. Dir Open-market buy
P
Ordinary Shares 3,000 $65.35 $196,058 5,500
2018-11-09 Andersen Svend EVP & President CHCI Open-market buy
P
Ordinary Shares 3,900 $63.01 $245,739 7,200
2018-10-08 Weninger Paul EVP, Quality Operations Equity grant / award
A · derivative
Restricted Stock Units 4,849 4,849
2018-08-14 Andersen Svend EVP & President CHCI Open-market buy
P
Ordinary Shares 7,200 $69.43 $499,896 7,200
2018-07-31 Kochan Sharon EVP, GM International Other disposed transaction
F
Ordinary Shares 1,095 $72.91 $79,836 10,764
2018-07-23 Winowiecki Ronald CFO Exercise / conversion
M · derivative
Restricted Stock Units 2,297 $0.00 $0 0
2018-07-23 Winowiecki Ronald CFO Other disposed transaction
F
Ordinary Shares 657 $75.97 $49,912 5,663
2018-07-23 Winowiecki Ronald CFO Exercise / conversion
M
Ordinary Shares 2,297 $75.97 $174,503 6,320
2018-06-29 Kochan Sharon EVP, GM International Equity grant / award
A
Ordinary Shares 1,828 $72.91 $133,279 11,859
2018-06-29 Janish Ronald Craig EVP, Global Op. & Supply Chain Exercise / conversion
M · derivative
Restricted Stock Units 827 0
2018-06-29 Janish Ronald Craig EVP, Global Op. & Supply Chain Other disposed transaction
F
Ordinary Shares 281 $72.91 $20,488 2,281
2018-06-29 Janish Ronald Craig EVP, Global Op. & Supply Chain Exercise / conversion
M
Ordinary Shares 827 $72.91 $60,297 2,562
2018-06-06 Samuels Theodore R. II Dir Exercise / conversion
M · derivative
Restricted Stock Units 4,265 0
2018-06-06 Samuels Theodore R. II Dir Exercise / conversion
M
Ordinary Shares 4,265 $73.22 $312,283 5,624
2018-05-17 Smith Jeffrey C Dir Open-market buy
P
Ordinary Shares 45,947 $75.89 $3,487,051 3,662,220
2018-05-17 Smith Jeffrey C Dir Open-market buy
P
Ordinary Shares 379 $75.89 $28,763 368,692
2018-05-17 Smith Jeffrey C Dir Open-market buy
P
Ordinary Shares 2,078 $75.89 $157,705 2,018,065
2018-05-17 Smith Jeffrey C Dir Open-market buy
P
Ordinary Shares 1,596 $75.89 $121,125 257,947
2018-05-16 Smith Jeffrey C Dir Open-market buy
P
Ordinary Shares 89,854 $75.83 $6,813,278 3,616,273
2018-05-16 Smith Jeffrey C Dir Open-market buy
P
Ordinary Shares 824 $75.83 $62,481 368,313
2018-05-16 Smith Jeffrey C Dir Open-market buy
P
Ordinary Shares 4,514 $75.83 $342,279 2,015,987
2018-05-16 Smith Jeffrey C Dir Open-market buy
P
Ordinary Shares 4,808 $75.83 $364,572 256,351
2018-05-15 Smith Jeffrey C Dir Equity grant / award
A · derivative
Restricted Stock Unit 3,971 3,971
2018-05-15 Smith Jeffrey C Dir Open-market buy
P
Ordinary Shares 20,746 $75.28 $1,561,666 3,526,419
2018-05-15 Smith Jeffrey C Dir Open-market buy
P
Ordinary Shares 101,001 $75.19 $7,594,689 3,505,673
2018-05-15 Smith Jeffrey C Dir Open-market buy
P
Ordinary Shares 321 $75.28 $24,163 367,489
2018-05-15 Smith Jeffrey C Dir Open-market buy
P
Ordinary Shares 1,565 $75.19 $117,679 367,168
2018-05-15 Smith Jeffrey C Dir Open-market buy
P
Ordinary Shares 1,761 $75.28 $132,560 2,011,473
2018-05-15 Smith Jeffrey C Dir Open-market buy
P
Ordinary Shares 8,574 $75.19 $644,715 2,009,712
2018-05-15 Smith Jeffrey C Dir Open-market buy
P
Ordinary Shares 7,178 $75.28 $540,328 251,543
2018-05-15 Smith Jeffrey C Dir Open-market buy
P
Ordinary Shares 34,947 $75.19 $2,627,812 244,365
2018-05-15 Smith Jeffrey C Dir Open-market buy
P
Ordinary Shares 12,594 $75.28 $948,020 446,645
2018-05-15 Smith Jeffrey C Dir Open-market buy
P
Ordinary Shares 61,313 $75.19 $4,610,382 434,051
2018-04-03 Kochan Sharon EVP, GM International Equity grant / award
A · derivative
Employee Stock Option Right to Buy 9,681 $82.82 $801,780 9,681
2018-04-02 Needham Jeffrey EVP, President CHC Americas Equity grant / award
A · derivative
Restricted Stock Units 6,169 6,169
2018-03-08 Janish Ronald Craig EVP, Global Op. & Supply Chain Equity grant / award
A · derivative
Employee Stock Option Right to Buy 8,679 $85.06 $738,236 8,679
2018-03-05 Roehrhoff Uwe CEO Open-market buy
P
Ordinary Shares 2,600 $82.43 $214,306 7,500
2018-03-05 Roehrhoff Uwe CEO Open-market buy
P
Ordinary Shares 4,900 $81.54 $399,556 4,900
2018-03-01 Winowiecki Ronald Interim CFO Exercise / conversion
M · derivative
Restricted Stock Units 1,776 $0.00 $0 0
2018-03-01 Winowiecki Ronald Interim CFO Other disposed transaction
F
Ordinary Shares 518 $79.57 $41,217 3,439
2018-03-01 Winowiecki Ronald Interim CFO Exercise / conversion
M
Ordinary Shares 1,776 $79.57 $141,316 3,957
2018-01-16 Roehrhoff Uwe CEO Equity grant / award
A · derivative
Restricted Stock Units 5,721 5,721
2017-12-28 KINGMA TODD W Executive VP, General Counsel Exercise / conversion
M · derivative
Restricted Stock Units 2,571 0
2017-12-28 KINGMA TODD W Executive VP, General Counsel Open-market sell
S
Ordinary Shares 1,500 $88.52 $132,780 17,252
2017-12-28 KINGMA TODD W Executive VP, General Counsel Other disposed transaction
F
Ordinary Shares 813 $87.27 $70,951 18,752
2017-12-28 KINGMA TODD W Executive VP, General Counsel Exercise / conversion
M
Ordinary Shares 2,571 $87.27 $224,371 19,565
2017-12-28 KINGMA TODD W Executive VP, General Counsel Other disposed transaction
F
Ordinary Shares 884 $87.27 $77,147 18,681
2017-12-28 KINGMA TODD W Executive VP, General Counsel Exercise / conversion
M
Ordinary Shares 2,571 $87.27 $224,371 19,565
2017-12-22 Winowiecki Ronald Interim CFO Exercise / conversion
M · derivative
Restricted Stock Units 846 0
2017-12-22 Winowiecki Ronald Interim CFO Other disposed transaction
F
Ordinary Shares 268 $87.01 $23,319 2,181
2017-12-22 Winowiecki Ronald Interim CFO Exercise / conversion
M
Ordinary Shares 846 $87.01 $73,610 2,449
2017-12-15 Wesolowski John EVP, President Rx Exercise / conversion
M · derivative
Restricted Stock Units 324 324
2017-12-15 Wesolowski John EVP, President Rx Other disposed transaction
F
Ordinary Shares 103 $86.50 $8,910 930
2017-12-15 Wesolowski John EVP, President Rx Exercise / conversion
M
Ordinary Shares 324 $86.50 $28,026 1,033
2017-12-14 Wesolowski John EVP, President Rx Open-market buy
P
Ordinary Shares 700 $85.80 $60,060 709
2017-12-07 Wesolowski John EVP, President Rx Open-market sell
S
Ordinary Shares 450 $83.09 $37,390 9
2017-11-29 Wesolowski John EVP, President Rx Open-market sell
S
Ordinary Shares 100 $87.66 $8,766 80
2017-11-29 Wesolowski John EVP, President Rx Open-market sell
S
Ordinary Shares 68 $87.64 $5,960 180
2017-11-28 Wesolowski John EVP, President Rx Open-market sell
S
Ordinary Shares 220 $86.86 $19,109 248
2017-11-03 HENDRICKSON JOHN T CEO Exercise / conversion
M · derivative
Restricted Stock Units 2,181 $0 0
2017-11-03 HENDRICKSON JOHN T CEO Other disposed transaction
F
Ordinary Shares 722 $82.36 $59,464 8,442
2017-11-03 HENDRICKSON JOHN T CEO Exercise / conversion
M
Ordinary Shares 2,181 $82.36 $179,627 9,164
2017-09-12 Janish Ronald Craig EVP, Global Op. & Supply Chain Open-market sell
S
Ordinary Shares 100 $88.70 $8,870 1,616
2017-09-12 Janish Ronald Craig EVP, Global Op. & Supply Chain Open-market sell
S
Ordinary Shares 161 $88.72 $14,284 1,716
2017-09-07 Wesolowski John EVP, President Rx Open-market sell
S
Ordinary Shares 202 $82.39 $16,620 847
2017-08-31 Kochan Sharon EVP, GM International Open-market sell
S
Ordinary Shares 1,500 $79.03 $118,545 10,349
2017-08-30 Farrington Thomas EVP and CIO Open-market sell
S
Ordinary Shares 616 $76.90 $47,370 2,724
2017-08-21 Janish Ronald Craig EVP, Global Op. & Supply Chain Other disposed transaction
F
Ordinary Shares 110 $77.58 $8,534 1,996
2017-08-21 Janish Ronald Craig EVP, Global Op. & Supply Chain Equity grant / award
A
Ordinary Shares 439 $77.58 $34,058 2,106
2017-08-21 Janish Ronald Craig EVP, Global Op. & Supply Chain Other disposed transaction
F
Ordinary Shares 65 $77.58 $5,043 1,667
2017-08-21 Janish Ronald Craig EVP, Global Op. & Supply Chain Exercise / conversion
M
Ordinary Shares 258 $77.58 $20,016 1,732
2017-08-21 Winowiecki Ronald Interim CFO Exercise / conversion
M · derivative
Restricted Stock Units 227 0
2017-08-21 Winowiecki Ronald Interim CFO Other disposed transaction
F
Ordinary Shares 122 $77.58 $9,465 1,603
2017-08-21 Winowiecki Ronald Interim CFO Equity grant / award
A
Ordinary Shares 386 $77.58 $29,946 1,725
2017-08-21 Winowiecki Ronald Interim CFO Other disposed transaction
F
Ordinary Shares 72 $77.58 $5,586 1,339
2017-08-21 Winowiecki Ronald Interim CFO Exercise / conversion
M
Ordinary Shares 227 $77.58 $17,611 1,411
2017-08-18 Farrington Thomas EVP and CIO Open-market sell
S
Ordinary Shares 765 $78.39 $59,972 2,105
2017-08-18 Farrington Thomas EVP and CIO Open-market sell
S
Ordinary Shares 100 $78.40 $7,840 2,870
2017-07-21 Winowiecki Ronald Interim CFO Equity grant / award
A · derivative
Restricted Stock Units 2,296 2,296
2017-07-21 Winowiecki Ronald Interim CFO Equity grant / award
A · derivative
Restricted Stock Units 2,297 2,297
2017-07-20 Alford Bradley A Dir Exercise / conversion
M · derivative
Restricted Stock Units 1,017 0
2017-07-20 Alford Bradley A Dir Other disposed transaction
F
Ordinary Shares 489 $75.51 $36,924 528
2017-07-20 Alford Bradley A Dir Exercise / conversion
M
Ordinary Shares 1,017 $75.51 $76,794 1,017
2017-06-21 BRLAS LAURIE Dir Exercise / conversion
M · derivative
Restricted Stock Units 778 0
2017-06-21 BRLAS LAURIE Dir Other disposed transaction
F
Ordinary Shares 374 $73.33 $27,425 12,557
2017-06-21 BRLAS LAURIE Dir Exercise / conversion
M
Ordinary Shares 778 $73.33 $57,051 12,931
2017-06-06 Parker Geoffrey M. Dir Equity grant / award
A · derivative
Restricted Stock Units 1,437 1,437
2017-06-06 Parker Geoffrey M. Dir Equity grant / award
A · derivative
Restricted Stock Units 4,265 4,265
2017-06-06 BRLAS LAURIE Dir Equity grant / award
A · derivative
Restricted Stock Units 5,331 5,331
2017-05-31 Needham Jeffrey EVP, President CHC Americas Exercise / conversion
M · derivative
Restricted Stock Units 515 $0.00 $0 0
2017-05-31 Needham Jeffrey EVP, President CHC Americas Other disposed transaction
F
Ordinary Shares 163 $72.85 $11,875 11,256
2017-05-31 Needham Jeffrey EVP, President CHC Americas Exercise / conversion
M
Ordinary Shares 515 $72.85 $37,518 11,419
2017-01-12 Samuels Theodore R. II Dir Equity grant / award
A · derivative
Restricted Stock Units 390 390
2017-01-12 Samuels Theodore R. II Dir Equity grant / award
A · derivative
Restricted Stock Units 390 390
2016-12-15 Wesolowski John EVP, President Rx Exercise / conversion
M · derivative
Restricted Stock Units 325 0
2016-12-15 Wesolowski John EVP, President Rx Other disposed transaction
F
Ordinary Shares 103 $82.61 $8,509 222
2016-12-15 Wesolowski John EVP, President Rx Exercise / conversion
M
Ordinary Shares 325 $82.61 $26,848 325
2016-11-25 Brown Judy L EVP, Business Ops & CFO Open-market sell
S
Ordinary Shares 2,097 $89.44 $187,556 10,007
2016-11-21 KINGMA TODD W Executive VP, General Counsel Open-market sell
S
Ordinary Shares 750 $88.68 $66,512 14,560
2016-11-17 Wesolowski John EVP, President Rx Equity grant / award
A · derivative
Restricted Stock Units 2,263 2,263
2016-11-17 Parker Geoffrey M. Dir Equity grant / award
A · derivative
Restricted Stock Units 511 511
2016-11-15 JANDERNOA MICHAEL J Dir Equity grant / award
G
Ordinary Shares 40,000 $0.00 $0 142,403
2016-11-15 JANDERNOA MICHAEL J Dir Other acquired transaction
J
Ordinary Shares 248,964 $0.00 $0 427,654
2016-10-24 Brown Judy L EVP, Business Ops & CFO Open-market sell
S
Ordinary Shares 2,092 $90.42 $189,159 12,104
2016-09-26 Brown Judy L EVP, Business Ops & CFO Open-market sell
S
Ordinary Shares 2,096 $96.76 $202,809 14,196
2016-09-09 KUNKLE GARY K JR Dir Exercise / conversion
M · derivative
Director Stock Option Right to Buy 5,814 $0.00 $0 0
2016-09-09 KUNKLE GARY K JR Dir Open-market sell
S
Ordinary Shares 100 $89.96 $8,996 25,687
2016-09-09 KUNKLE GARY K JR Dir Open-market sell
S
Ordinary Shares 2,000 $89.95 $179,910 25,787
2016-09-09 KUNKLE GARY K JR Dir Open-market sell
S
Ordinary Shares 2,414 $89.95 $217,139 27,787
2016-09-09 KUNKLE GARY K JR Dir Open-market sell
S
Ordinary Shares 1,300 $89.94 $116,928 30,201
2016-09-09 KUNKLE GARY K JR Dir Exercise / conversion
M
Ordinary Shares 5,814 $16.77 $97,501 31,501
2016-09-08 MORRIS HERMAN JR Dir Exercise / conversion
M · derivative
Director Stock Option Right to Buy 5,814 $0.00 $0 0
2016-09-08 MORRIS HERMAN JR Dir Open-market sell
S
Ordinary Shares 1,073 $90.95 $97,595 9,352
2016-09-08 MORRIS HERMAN JR Dir Exercise / conversion
M
Ordinary Shares 5,814 $16.77 $97,501 10,425
2016-08-29 Michaud James R EVP, Chief HR Officer Equity grant / award
A · derivative
Restricted Stock Units 4,492 4,492
2016-08-26 Janish Ronald Craig EVP, Global Op. & Supply Chain Other acquired transaction
I
Ordinary Shares 3,544 $88.61 $313,998 4,328
2016-08-22 KINGMA TODD W Executive VP, General Counsel Exercise / conversion
M · derivative
Restricted Stock Units 1,536 $0.00 $0 0
2016-08-22 KINGMA TODD W Executive VP, General Counsel Other disposed transaction
F
Ordinary Shares 486 $91.52 $44,479 15,310
2016-08-22 KINGMA TODD W Executive VP, General Counsel Exercise / conversion
M
Ordinary Shares 1,536 $91.52 $140,575 15,796
2016-08-22 KINGMA TODD W Executive VP, General Counsel Other disposed transaction
F
Ordinary Shares 1,287 $91.52 $117,786 14,260
2016-08-22 KINGMA TODD W Executive VP, General Counsel Equity grant / award
A
Ordinary Shares 4,070 $91.52 $372,486 15,547
2016-08-22 Weninger Paul EVP, Quality Operations Exercise / conversion
M · derivative
Restricted Stock Units 188 $0.00 $0 0
2016-08-22 Weninger Paul EVP, Quality Operations Exercise / conversion
M
Ordinary Shares 188 $91.52 $17,206 2,296
2016-08-22 Weninger Paul EVP, Quality Operations Equity grant / award
A
Ordinary Shares 499 $91.52 $45,668 2,108
2016-08-22 Janish Ronald Craig EVP, Global Op. & Supply Chain Exercise / conversion
M · derivative
Restricted Stock Units 301 $0.00 $0 0
2016-08-22 Janish Ronald Craig EVP, Global Op. & Supply Chain Other disposed transaction
F
Ordinary Shares 112 $91.52 $10,250 1,474
2016-08-22 Janish Ronald Craig EVP, Global Op. & Supply Chain Exercise / conversion
M
Ordinary Shares 301 $91.52 $27,548 1,586
2016-08-22 Janish Ronald Craig EVP, Global Op. & Supply Chain Other disposed transaction
F
Ordinary Shares 290 $91.52 $26,541 1,285
2016-08-22 Janish Ronald Craig EVP, Global Op. & Supply Chain Equity grant / award
A
Ordinary Shares 796 $91.52 $72,850 1,575
2016-08-19 KINGMA TODD W Executive VP, General Counsel Exercise / conversion
M · derivative
Restricted Stock Units 1,692 $0.00 $0 0
2016-08-19 KINGMA TODD W Executive VP, General Counsel Other disposed transaction
F
Ordinary Shares 535 $91.83 $49,129 11,477
2016-08-19 KINGMA TODD W Executive VP, General Counsel Exercise / conversion
M
Ordinary Shares 1,692 $91.83 $155,376 12,012
2016-06-21 HENDRICKSON JOHN T CEO Equity grant / award
A · derivative
Employee Stock Option Right to Buy 26,968 $96.45 $2,601,064 26,968
2016-06-21 HENDRICKSON JOHN T CEO Equity grant / award
A · derivative
Restricted Stock Units 4,997 4,997
2016-05-19 BRLAS LAURIE Dir Equity grant / award
A · derivative
Restricted Stock Units 3,263 3,263
2016-05-19 KUNKLE GARY K JR Dir Equity grant / award
A · derivative
Restricted Stock Units 3,263 3,263
2016-05-04 COHEN GARY M Dir Exercise / conversion
M · derivative
Restricted Stock Units 924 $0.00 $0 0
2016-05-04 COHEN GARY M Dir Other disposed transaction
F
Ordinary Shares 444 $95.70 $42,491 13,351
2016-05-04 COHEN GARY M Dir Exercise / conversion
M
Ordinary Shares 924 $95.70 $88,427 13,795

Regulatory Activity

Last 12 months to 2025-04-29
Insider Filings (Forms 3/4/5) — 12 months
23
Material Event Filings (8-K) — 12 months
9

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count
For informational purposes only — not guaranteed to be accurate or complete.